Signal Sequence Receptor, alpha (SSR1) (Middle Region) Peptide
SSR1
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN984457
$160.46
Plus shipping costs $50.00
100 μg
Shipping to:
United States
Delivery in 11 to 16 Business Days
Quick Overview for Signal Sequence Receptor, alpha (SSR1) (Middle Region) Peptide (ABIN984457)
Target
SSR1
(Signal Sequence Receptor, alpha (SSR1))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Sequence
- FTNKGTEDFI VESLDASFRY PQDYQFYIQN FTALPLNTVV PPQRQATFEY
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-SSR1 Antibody(ARP45428_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- SSR1 (Signal Sequence Receptor, alpha (SSR1))
-
Background
-
The signal sequence receptor (SSR) is a glycosylated endoplasmic reticulum (ER) membrane receptor associated with protein translocation across the ER membrane. The SSR consists of 2 subunits, a 34-kD glycoprotein encoded by this gene and a 22-kD glycoprotein.
Alias Symbols: DKFZp781N23103, TRAPA
Protein Interaction Partner: DKC1,EEF1A1,NUP54,PTN,UTP14A,DKC1,EEF1A1,PTN,UTP14A
Protein Size: 286 -
Molecular Weight
- 32 kDa
-
Gene ID
- 6745
-
NCBI Accession
- NM_003144, NP_003135
-
UniProt
- P43307
Target
-
You are here:
